Funded startups/Immorta Bio, Inc.
IB

Immorta Bio, Inc.

SEC filing
Biotechnology · Miami Beach, FL
Form D on EDGAR
Amount raised$613Ksold at filing
Total offering$5M$4.4M still open
Investors in the raise6count reported to the SEC
FiledOct 16, 2026first sale Nov 5, 2024

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Boris ReznikExecutive Officer

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DOct 16, 2026$613K$5MEDGAR
DJan 8, 2026$450K$500KEDGAR